Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Ferlay J, Soerjomataram I, Ervik M et al GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from:
http://globocan.iarc.fr
, accessed on 20/9/2016
2. Sato S, Itamochi H (2014) Neoadjuvant chemotherapy in advanced ovarian cancer: latest results and place in therapy. Ther Adv Med Oncol 6(6):293–304.
https://doi.org/10.1177/1758834014544891
3. Herzog TJ (2004) Recurrent ovarian cancer: how important is it to treat to disease progression? Clin Cancer Res 10(22):7439–7449.
https://doi.org/10.1158/1078-0432.CCR-04-0683
4. Ahmed-Lecheheb D, Joly F (2016) Ovarian cancer survivors’ quality of life: a systematic review. J Cancer Surviv 10(5):789–801.
https://doi.org/10.1007/s11764-016-0525-8
5. Zhou Y, Irwin ML, Ferrucci LM, McCorkle R, Ercolano EA, Li F, Stein K, Cartmel B (2016) Health-related quality of life in ovarian cancer survivors: results from the American Cancer Society’s Study of Cancer Survivors—I. Gynecol Oncol 141(3):543–549.
https://doi.org/10.1016/j.ygyno.2016.04.006
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献